2022 Abstracts
Real-world outcomes in patients with neovascular age-related macular degeneration treated with Brolucizumab and other intravitreal vascular endothelial growth factor inhibitors: a retrospective observational study
Author: Lorenzo Fabozzi
Co-authors: Saad Younis, Antonio Valentino Giugliano, Filomena Palmieri
